Skip to main content
main-content

Onkologie und Hämatologie | Zeitschrift

memo - Magazine of European Medical Oncology 2/2022
memo - Magazine of European Medical Oncology

Ausgabe 2/2022

share
TEILEN
insite
SUCHEN

Inhaltsverzeichnis (20 Artikel)

01.06.2022 | editorial

ESMO 2021
Univ.-Prof. Dr. Rupert Bartsch

01.06.2022 | editorial

New targeted therapies/small molecules in oncology and hematology
Assoc.-Prof. PD Dr. Anna Sophie Berghoff

01.06.2022 | editorial

COVID-19 crisis and cancer
Assoc.-Prof. Dr. Rupert Bartsch, Prof. Dr. Wolfgang Hilbe

01.06.2022 | editorial

COVID-19: New disease mechanism is simultaneously a therapeutic target
Prof. Dr. Clemens A. Schmitt

01.04.2022 | short review

Renal cell carcinoma—presentation highlights from the ESMO Congress 2021
Assoc. Prof. Georg C. Hutterer MD, Assoc. Prof. Martin Pichler MD

14.04.2022 | review

Highlights ESMO 2021—lung cancer
Dr. Markus Rauter

Open Access 06.05.2022 | short review

ESMO 2021—my top three abstracts in breast cancer
Christoph Suppan MD

Open Access 28.04.2022 | short review

ESMO 2021—highlights in colorectal cancer
Lukas Weiss MD, PhD

31.03.2022 | short review

Breast Cancer—Essential news of current guidelines
Kathrin Strasser-Weippl MD, MBA

Open Access 14.04.2022 | short review

Agony of choice—selecting chronic lymphocytic leukemia treatment in 2022
Jan-Paul Bohn M.D. PhD.

Open Access 04.02.2022 | short review

Antibody–drug conjugates—the magic bullet?
Marie-Bernadette Aretin

Open Access 23.12.2021 | short review

Current state of clinical development of TROP2-directed antibody–drug conjugates for triple-negative breast cancer
Maximilian Marhold

22.12.2021 | short review

New targeted therapies in kidney cancer
Karl Mayrhofer MD, Dora Niedersüß-Beke MD, MBA

Open Access 21.01.2022 | short review

Tracking mutation and drug-driven alterations of oncokinase conformations
Andreas Feichtner, Valentina Kugler, Selina Schwaighofer, Thomas Nuener, Jakob Fleischmann, Dr. Eduard Stefan

21.01.2022 | case report

Systemic capillary leak syndrome following granulocyte colony-stimulating factor therapy in a T-lymphoblastic leukemia/lymphoma patient: a case report
Ahmed H. Al Sharie, Yazan O. Al Zu’bi, Sarah Al Sharie, Hawra A. Baydoun, Farah H. Atawneh, Osama Alshari, Dima Albals

15.06.2021 | case report

Hemophagocytic lymphohistocytosis in a COVID-19 patient in the acute phase: case report
Maher Salamoon MD, Mazen Kenj

06.05.2022 | original report

High mortality in patients with active malignancy and severe COVID-19
Results from an Austrian multicenter registry during the first period of the COVID-19 pandemic
Simon Udovica, Nino Müser, Agnes Pechlaner, Andreas Reichinger, Christoph Aichinger, Kathrin Strasser-Weippl, Holger Rumpold, Andreas Petzer, Ewald Wöll, Wolfgang Hilbe, Ercan Müldür

11.04.2022 | interview

Cardiopulmonary sequelae of COVID-19

09.05.2022 | case report

Neurotoxicity as a rare side effect of immune checkpoint inhibitors. A case report and review of the literature
Simon Udovica, Kathrin Strasser-Weippl, Eva Fischer, Dora Niedersüß-Beke

10.05.2022 | case report

Immunotherapy pitfall: sarcoid-like reaction mimicking disease progression in advanced melanoma treated with nivolumab
Beatrix Mutschlechner, Susanne Dertinger, Felix Offner, Veronika Buck, Alexander Becherer, Klaus Gasser, Bernd Hartmann, Thomas Winder MD, PhD